Structural Heart Market is anticipated to grow at a CAGR of 10.5% and worth US$ 13,850.2 Million by 2025 | Abbott, Medtronic, Boston Scientific Corporation

The report provides a comprehensive overview of the Structural Heart market, presenting insights into the key factors driving and restraining its growth. This report also takes a close and analytical look at the various companies that strive for a higher share of the global Structural Heart market.

The rise in technological advancement has led to various innovations for the products and treatment services that enables the surgeon, physicians and other healthcare providers to provide best health to their patients. The innovations are not only limited to the healthcare facilities nevertheless they are extended to the programs that are being designed for the patients to get benefit out of the treatment facilities. Food and Drug Administration (FDA) has approved various therapies that are limited to the selected groups of the patients. There some personal healthcare provider who analyze the heart condition and available treatment of choices.

Get Sample Copy of this Report at – https://www.theinsightpartners.com/sample/TIPHE100001164/

Some of the leading key players are Abbott, Medtronic, Boston Scientific Corporation, CryoLife,  Inc, Edward Lifesciences Corporation, LivaNova Plc, Lepu Medical, Braile Biomedica, Labcor Laboratories Ltda, Aran Biomedical Teoranta

For instance, Premier Health is among those providers who provides innovative structural heart services which include alcohol septal ablation which treats hypertrophic cardiomyopathy with the use of catheter-based technology, balloon valvuloplasty which uses a transcatheter approach for widening up a stiff and narrow heart valves, atrial septal defect transcatheter repair which closes an opening between the heart’s left and right atrium without surgery and such more services are being provided by the service providers.

The cardiac arrest or the other heart related diseases are wide spreading incidence and are impacting severely on the public health and wellbeing. The cardiovascular disease are the second leading cause of death across the world. For instance, according to World Health Organization (WHO) approximately 17.7 million people died in 2015 due to the cardiovascular diseases, the number contributes to the 31% of the global deaths. The among these deaths it was estimated that near about 7.4 million deaths were due to coronary heart diseases and near about 6.7 million deaths were due to the heart stroke. Among the 17 million deaths the premature deaths were contributed due to non-communicable diseases in 2015, this number relates approximately to 82% were in low and middle-income countries, and approximately 37% were due to CVDs. Therefore, various strategies and initiations are being taken to control the cardiovascular diseases.

Avail Discount on this Report at – https://www.theinsightpartners.com/discount/TIPHE100001164/

The global structural heart market by product was led by occluders segment. In 2017, the occluders segment held a largest market share of 42.0% of the structural heart market, by product. The segment is also expected to dominate the market during the year 2025, due to benefits such as, 50% of reduction in the meshwork material on the left atrial side and eliminates the left atrial disc microsrew, minimizes the risk of thrombus formation and damage to the distal wall of the left atrium during the implantation procedure.

The structural heart market by procedure was segmented into surgical aortic valve replacement, transcatheter aortic valve replacement, mitral repair and left atrial appendage closure. The surgical aortic valve replacement segment held the largest share of the market, by procedure. The segment is also likely to dominate during the forecast period, as it helps in restoring the normal blood flow, prolong life and help to preserve the function of heart muscles.

The structural heart market by end user was segmented into hospital, ambulatory surgical centers and cardiac centers. The hospitals segment held the largest share of the market, by end user. The segment held a market share of around 49.9% during the year 2017 and is anticipated to dominate by 2025, among the end users.

North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period. North American market is driven by the factors such as, rising prevalence of heart diseases, growing number of regulatory approvals and product launches in the region.

Market Segmentation:

By Product

  • Occluders
  • Annuloplasty Rings
  • Heart Valve Balloons
  • Others 

By Procedure

  • Surgical Aortic Valve Replacement
  • Transcatheter Aortic Valve Replacement
  • Mitral Repair

Left Atrial Appendage Closure 

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Centers

Geographically, the global market fragmented across several regions such as North America, Latin America, Asia-Pacific, Africa, and the Middle East on the basis of different business verticals. In the era of developing and developed countries Structural Heart Market are holding the highest share. A clear picture of these market has been provided by presenting the market with distinctive info graphics.

Acquisitions and expansions were observed as the most adopted strategy in global structural heart industry. Few of the acquisitions and expansions made by the players in the market are listed below:

2018: In July, 2018, Boston Scientific Corporation announced signing of agreement to acquire Claret Medical, Inc., a privately-held company that has developed and commercialized the Sentinel Cerebral Embolic Protection System.

2017: In November, 2017, Edwards Lifesciences Corporation, announced it expansion, the expansion was done in the Costa Rica a new manufacturing plant was started.

Purchase this Report at – https://www.theinsightpartners.com/buy/TIPHE100001164/

The most vital key factors in the businesses have been elaborated to get thorough and accurate data of market dynamics. Rising needs and popularity of Structural Heart Market sector is driving the flow of the market towards progress. In addition to this, it lists the factors which are restraining the growth of the market.

Reason to Buy

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Structural Heart Market

– Highlights key business priorities in order to assist companies to realign their business strategies.

– The key findings and recommendations highlight crucial progressive industry trends in the Structural Heart Market, thereby allowing players to develop effective long term strategies.

– Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

– Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

– Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

Call: +1-646-491-9876

Email: [email protected]

Website: https://www.theinsightpartners.com/

Posted by on Wednesday June 12 2019, 3:31 PM EDT. All trademarks acknowledged. Filed under Biotechnology, Diagnostics, Healthcare, Life Sciences, Medical Devices, Pharmaceuticals. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Log in